{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:24:04Z","timestamp":1790796244244,"version":"4.1.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1053\/j.ajkd.2018.09.013","type":"journal-article","created":{"date-parts":[[2018,12,7]],"date-time":"2018-12-07T17:47:19Z","timestamp":1544204839000},"page":"615-619","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Acute Thrombotic Microangiopathy and Cortical Necrosis Following Administration of Alemtuzumab: A Case Report"],"prefix":"10.1053","volume":"73","author":[{"given":"Ashley A.","family":"Liou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brent M.","family":"Skiver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Yates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Persad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew M.","family":"Farland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael V.","family":"Rocco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1053\/j.ajkd.2018.09.013_bib1","doi-asserted-by":"crossref","first-page":"16414","DOI":"10.3390\/ijms160716414","article-title":"Alemtuzumab in multiple sclerosis: mechanism of action and beyond","volume":"16","author":"Ruck","year":"2015","journal-title":"Int J Mol Sci"},{"issue":"7","key":"10.1053\/j.ajkd.2018.09.013_bib2","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1056\/NEJMc0800484","article-title":"Anti-glomerular basement membrane disease after alemtuzumab","volume":"359","author":"Clatworthy","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1053\/j.ajkd.2018.09.013_bib3","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.msard.2012.07.002","article-title":"Case report of anti-glomerular basement membrane disease following alemtuzumab treatment of relapsing-remitting\u00a0multiple sclerosis","volume":"2","author":"Meyer","year":"2013","journal-title":"Mult Scler Relat Disord"},{"issue":"4","key":"10.1053\/j.ajkd.2018.09.013_bib4","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1182\/blood-2014-11-611335","article-title":"Drug-induced thrombotic microangiopathy: a systematic review of published reports","volume":"125","author":"Al-Nouri","year":"2015","journal-title":"Blood"},{"issue":"1","key":"10.1053\/j.ajkd.2018.09.013_bib5","first-page":"11","article-title":"Acute renal failure and disseminated intravascular coagulation following an idiosyncratic reaction to alemtuzumab (Campath 1H) or fludarabine","volume":"90","author":"Osborne","year":"2005","journal-title":"Haematologica"},{"issue":"5","key":"10.1053\/j.ajkd.2018.09.013_bib6","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/ajh.23960","article-title":"Drug-induced thrombotic microangiopathy: experience of the Oklahoma Registry and the BloodCenter of Wisconsin","volume":"90","author":"Reese","year":"2015","journal-title":"Am J Hematol"},{"issue":"1","key":"10.1053\/j.ajkd.2018.09.013_bib7","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s40263-016-0394-8","article-title":"Alemtuzumab use in clinical practice: recommendations from European multiple sclerosis experts","volume":"31","author":"Berger","year":"2017","journal-title":"CNS Drugs"},{"issue":"6","key":"10.1053\/j.ajkd.2018.09.013_bib8","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1177\/1756285615605429","article-title":"Monoclonal antibody therapies for the treatment of relapsing-remitting multiple sclerosis: differentiating mechanisms and clinical outcomes","volume":"8","author":"Lycke","year":"2015","journal-title":"Ther Adv Neurol Disord"},{"issue":"1-4","key":"10.1053\/j.ajkd.2018.09.013_bib9","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.trim.2013.09.004","article-title":"Acute transplant glomerulopathy with monocyte rich infiltrate","volume":"29","author":"Lenihan","year":"2013","journal-title":"Transpl Immunol"},{"issue":"6","key":"10.1053\/j.ajkd.2018.09.013_bib10","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1055\/s-0035-1556587","article-title":"Thrombosis, microangiopathies, and inflammation","volume":"41","author":"Matevosyan","year":"2015","journal-title":"Semin Thromb Hemost"},{"issue":"5","key":"10.1053\/j.ajkd.2018.09.013_bib11","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/00062752-200109000-00004","article-title":"Drug-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome","volume":"8","author":"Medina","year":"2001","journal-title":"Curr Opin Hematol"},{"issue":"19","key":"10.1053\/j.ajkd.2018.09.013_bib12","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1056\/NEJMc1410951","article-title":"Syndromes of thrombotic microangiopathy","volume":"371","author":"George","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1053\/j.ajkd.2018.09.013_bib13","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1432-2277.2006.00445.x","article-title":"Hemolytic uremic syndrome following Campath-1H induction","volume":"20","author":"Bonatti","year":"2007","journal-title":"Transpl Int"},{"issue":"3","key":"10.1053\/j.ajkd.2018.09.013_bib14","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1093\/rheumatology\/35.3.231","article-title":"CAMPATH-1H in rheumatoid arthritis\u2014an intravenous dose-ranging study","volume":"35","author":"Isaacs","year":"1996","journal-title":"Br J Rheumatol"},{"issue":"1","key":"10.1053\/j.ajkd.2018.09.013_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40893-016-0011-1","article-title":"Hands on alemtuzumab-experience from clinical practice: whom and how to treat","volume":"1","author":"Hassoun","year":"2016","journal-title":"Mult Scler Demyelinating Disord"},{"issue":"4","key":"10.1053\/j.ajkd.2018.09.013_bib16","first-page":"635","article-title":"Adrenocorticotropic hormone ameliorates acute kidney injury by steroidogenic-dependent and -independent mechanisms","volume":"83","author":"Si","year":"2013","journal-title":"Kidney\u00a0Int"},{"issue":"18","key":"10.1053\/j.ajkd.2018.09.013_bib17","first-page":"5858","article-title":"Thrombotic microangiopathy with targeted cancer agents","volume":"17","author":"Blake-Haskins","year":"2011","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1053\/j.ajkd.2018.09.013_bib18","first-page":"281","article-title":"Hematologic disorders after solid organ transplantation","volume":"2010","author":"Smith","year":"2010","journal-title":"ASH Education Program Book"},{"issue":"4","key":"10.1053\/j.ajkd.2018.09.013_bib19","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1046\/j.1526-0968.2001.00316.x","article-title":"Membrane plasmapheresis in the United States: a review over the last 20 years","volume":"5","author":"Siami","year":"2001","journal-title":"Ther Apher Dial"},{"issue":"3","key":"10.1053\/j.ajkd.2018.09.013_bib20","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/bjh.12629","article-title":"The mechanisms of action of plasma exchange","volume":"164","author":"Reeves","year":"2014","journal-title":"Br J Haematol"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638618310552?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638618310552?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T03:19:58Z","timestamp":1759461598000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638618310552"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S0272638618310552"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2018.09.013","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acute Thrombotic Microangiopathy and Cortical Necrosis Following Administration of Alemtuzumab: A Case Report","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2018.09.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}]}}